Company / Current Liabilities
Sonoma Pharmaceuticals, Inc. Current Liabilities History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$4.1M
FY2025
5-year range
$3.7M / $5.8M
FY2021-FY2025
Trend
+10.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has fluctuated over the past 9 years, ranging from $3M in FY2018 to $6M in FY2022.
Based on SEC 10-K filings.
$4M in FY2025 with a 5-year CAGR of -3.4%.
Increased from $4M to $4M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -11.0%
- 5-Year CAGR
- -3.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -3.4%, indicating a declining trend.
- In FY2025, current liabilities increased 10.1% year-over-year.
- Peak current liabilities was recorded in FY2022.
- Lowest current liabilities in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | - | - |
| FY2025 | $4.1M | +10.1% |
| FY2024 | $3.7M | +0.1% |
| FY2023 | $3.7M | -36.1% |
| FY2022 | $5.8M | +42.7% |
| FY2021 | $4.1M | -16.2% |
| FY2020 | $4.9M | +35.5% |
| FY2019 | $3.6M | +10.1% |
| FY2018 | $3.3M | -0.8% |
| FY2017 | $3.3M | -7.4% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026